Predictions
Zoetis Inc. A
Start price
Target price
Perf. (%)
€128.74
-
-
Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
-
-3.64%
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
-
-3.64%
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
-
-3.64%
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Inovio Pharma
Start price
Target price
Perf. (%)
€11.30
€13.00
-18.14%
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
EBIT decline/stagnation expected
Perrigo Co. plc
Start price
Target price
Perf. (%)
€37.00
-
-9.73%
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
€19.00
-19.48%
Undervalued
High dividend yield expected
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
€19.00
-19.48%
Undervalued
High dividend yield expected
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
€19.00
-19.48%
Undervalued
High dividend yield expected
GlaxoSmithKline plc
Start price
Target price
Perf. (%)
€14.65
€17.30
-2.36%
Could be very worthwhile Investment >20% year
High dividend yield expected
Good rating
Small Risks for its business
GlaxoSmithKline plc
Start price
Target price
Perf. (%)
€14.65
€17.30
-2.36%
Could be very worthwhile Investment >20% year
High dividend yield expected
Good rating
Small Risks for its business
Heat Biologics Inc.
Start price
Target price
Perf. (%)
€11.10
-
-40.54%
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Some uniques
Canopy Growth Corp
Start price
Target price
Perf. (%)
€36.00
-
-24.63%
Probably not worthwhile Investment
High risks for its business
Few uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
-
-4.90%
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
-
-4.90%
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€82.00
€90.00
-9.15%
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
€200.00
-1.99%
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.36
€100.00
-0.45%
Could be very worthwhile Investment >20% year
Advaxis Inc.
Start price
Target price
Perf. (%)
€0.62
€60.00
12.61%
Could be very worthwhile Investment >20% year
Teligent Inc.
Start price
Target price
Perf. (%)
€0.99
-
-25.89%
Could be very worthwhile Investment >20% year
Zosano Pharma
Start price
Target price
Perf. (%)
€0.90
-
17.32%
Could be very worthwhile Investment >20% year